Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids

Detalhes bibliográficos
Autor(a) principal: Yanik, Burcu
Data de Publicação: 2009
Outros Autores: Ayrim, Aylin, Ozol, Duygu, Koktener, Asli, Gokmen, Derya
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/18013
Resumo: OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant.
id USP-19_81c1000132b504878c2a5820fad392e2
oai_identifier_str oai:revistas.usp.br:article/18013
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids AsthmaObesityOsteoporosisBone mineral densitometryInhaled steroids OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant. Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2009-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/1801310.1590/S1807-59322009000400008Clinics; Vol. 64 No. 4 (2009); 313-318 Clinics; v. 64 n. 4 (2009); 313-318 Clinics; Vol. 64 Núm. 4 (2009); 313-318 1980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/18013/20078Yanik, BurcuAyrim, AylinOzol, DuyguKoktener, AsliGokmen, Deryainfo:eu-repo/semantics/openAccess2012-05-22T18:51:19Zoai:revistas.usp.br:article/18013Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2012-05-22T18:51:19Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
title Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
spellingShingle Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
Yanik, Burcu
Asthma
Obesity
Osteoporosis
Bone mineral densitometry
Inhaled steroids
title_short Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
title_full Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
title_fullStr Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
title_full_unstemmed Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
title_sort Influence of obesity on bone mineral density in postmenopausal asthma patients undergoing treatment with inhaled corticosteroids
author Yanik, Burcu
author_facet Yanik, Burcu
Ayrim, Aylin
Ozol, Duygu
Koktener, Asli
Gokmen, Derya
author_role author
author2 Ayrim, Aylin
Ozol, Duygu
Koktener, Asli
Gokmen, Derya
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Yanik, Burcu
Ayrim, Aylin
Ozol, Duygu
Koktener, Asli
Gokmen, Derya
dc.subject.por.fl_str_mv Asthma
Obesity
Osteoporosis
Bone mineral densitometry
Inhaled steroids
topic Asthma
Obesity
Osteoporosis
Bone mineral densitometry
Inhaled steroids
description OBJECTIVES: The etiology of osteoporosis in asthma is complex as various factors contribute to its pathogenesis. The purpose of our study was to investigate the effects of obesity and inhaled steroids, as well as the severity and duration of asthma, on osteoporosis in postmenopausal asthma patients as compared to healthy controls. METHODS: A total of 46 patients with asthma and 60 healthy female controls, all postmenopausal, were enrolled in our study. Bone mineral density was assessed at the lumbar spine and hip using a Lunar DPX-L densitometer. RESULTS: Bone mineral density (BMD) scores were comparable between the asthmatic and control groups, with average scores of 0.95 ± 0.29 and 0.88 ± 0.14 g/cm², respectively. Likewise, osteoporosis was diagnosed in a similar percentage of patients in the asthmatic (39.1%) and control (43.3%) groups. Bone fracture was identified in four patients with asthma (8.6%) and in six patients from the control group (10%). We could not detect any relationship between BMD and duration of asthma, asthma severity, inhaled steroids or body mass index (BMI). There was no difference between the two groups with respect to age or years since menopause. Although asthma patients were more likely to be overweight and presented higher BMD scores on average than the control subjects, these differences were not statistically significant. CONCLUSIONS: There is a slight positive protective effect of high BMI against osteoporosis in asthma patients, but this effect is overcome by time and menopause status. Therefore, the protective effect of obesity against osteoporosis in asthma patients seems to not be significant.
publishDate 2009
dc.date.none.fl_str_mv 2009-04-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18013
10.1590/S1807-59322009000400008
url https://www.revistas.usp.br/clinics/article/view/18013
identifier_str_mv 10.1590/S1807-59322009000400008
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/18013/20078
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; Vol. 64 No. 4 (2009); 313-318
Clinics; v. 64 n. 4 (2009); 313-318
Clinics; Vol. 64 Núm. 4 (2009); 313-318
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1800222754718351360